-
Taxonomy & unit
-
ratio: %
-
Description
-
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
-
Summary
-
Eiger BioPharmaceuticals, Inc. annual/quarterly Operating Margin history and growth rate from Q4 2021 to Q4 2022.
- Eiger BioPharmaceuticals, Inc. Operating Margin for the quarter ending December 31, 2022 was -688 %, a 8.54% decline year-over-year.
- Eiger BioPharmaceuticals, Inc. annual Operating Margin for 2023 was -455 %, a 33.8% increase from 2022.
- Eiger BioPharmaceuticals, Inc. annual Operating Margin for 2022 was -688 %, a 8.54% decline from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)